Erythropoietin May Improve the Ultrafiltration in Peritoneal Dialysis: A Case Report

Abstract

Get full access to this article

View all access options for this article.

References

Raine

A.E.G.

Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: Implications of erythropoietin therapy.

Lancet 1988; 1: 97–99.

Steinhauer

H.B.

, Lubrich-Birkner

, Dreyling

K.W.

Human recombinant erythropoietin (rhEPO) increases peritoneal ultrafiltration in CAPD patients (Abstract)

XXVIth Congress EDTA, June 11–15, 1989, Göteborg, Sweden.

Houston

M.C.

, McChesney

J.A.

, Chatterjee

Pericaridal effusion associated with minoxidil therapy.

Arch Intern Med. 1981; 141: 69–71.

Frenken

L.A.M.

, Coppeus

P.J.W.

, Tiggeler

RGWL

Clinical study of the efficacy and tolerance of recombinant human erythropoietin after intraperitoneal administration in patients treated with continuous ambulatory peritoneal dialysis. (Abstract) XXVlth Congress EDTA, June 11–15, 1989 Göteborg, Sweden.